http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2842175-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e255c9d46e7982a6e7dcd176aaf93031 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5685 |
filingDate | 2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc763046c61ecccc1838d8306b7eeea7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18679bc6e55cb2603919e8de51a68832 |
publicationDate | 2013-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2842175-A1 |
titleOfInvention | Tablet containing dehydroepiandrosterone (dhea) |
abstract | The present invention relates to a tablet having a weight of 30-200 mg and consisting of: 60-100 wt.% of granules consisting of: - 50-90% by weight of the granules of dehydroepiandrosterone (DHEA); - 6-35%) by weight of the granules of microcrystalline cellulose; - 0-20%) by weight of the granules of one or more other pharmaceutically acceptable granule ingredients; and 0-40 wt.%) of one or more other pharmaceutically acceptable tablet components. These tablets can suitably be used to orally administer DHEA in dosages of around 50 mg and are sufficiently small to be incorporated in, for instance, ordinary oral contraceptive blister packs. |
priorityDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.